Deutsche Bank’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-46,225
| Closed | -$74K | – | 3596 |
|
|
2025
Q1 | $74K | Buy |
+46,225
| New | +$74K | ﹤0.01% | 3262 |
|
|
2024
Q4 | – | Sell |
-39,180
| Closed | -$223K | – | 3555 |
|
|
2024
Q3 | $223K | Buy |
39,180
+9,332
| +31% | +$53.2K | ﹤0.01% | 2840 |
|
|
2024
Q2 | $138K | Buy |
+29,848
| New | +$138K | ﹤0.01% | 2967 |
|
|
2023
Q2 | – | Sell |
-25,932
| Closed | -$81.4K | – | 3749 |
|
|
2023
Q1 | $81.4K | Buy |
25,932
+8,162
| +46% | +$25.6K | ﹤0.01% | 3400 |
|
|
2022
Q4 | $105K | Buy |
17,770
+281
| +2% | +$1.66K | ﹤0.01% | 3293 |
|
|
2022
Q3 | $153K | Sell |
17,489
-939
| -5% | -$8.22K | ﹤0.01% | 3080 |
|
|
2022
Q2 | $139K | Sell |
18,428
-8,562
| -32% | -$64.6K | ﹤0.01% | 3333 |
|
|
2022
Q1 | $654K | Sell |
26,990
-29,050
| -52% | -$704K | ﹤0.01% | 2580 |
|
|
2021
Q4 | $1.81M | Buy |
56,040
+31,854
| +132% | +$1.03M | ﹤0.01% | 2055 |
|
|
2021
Q3 | $1.08M | Buy |
24,186
+2,327
| +11% | +$104K | ﹤0.01% | 2551 |
|
|
2021
Q2 | $828K | Buy |
21,859
+14,645
| +203% | +$555K | ﹤0.01% | 2879 |
|
|
2021
Q1 | $267K | Sell |
7,214
-648
| -8% | -$24K | ﹤0.01% | 3448 |
|
|
2020
Q4 | $260K | Buy |
+7,862
| New | +$260K | ﹤0.01% | 3282 |
|